ID

42629

Descripción

Testosterone Replacement in Diabetes With Vascular Disease (Version 2); ODM derived from: https://clinicaltrials.gov/show/NCT00355537

Link

https://clinicaltrials.gov/show/NCT00355537

Palabras clave

Versiones (2)
  1. 4/3/17 4/3/17 -
  2. 17/9/21 17/9/21 -
Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus NCT00355537

Inglés

Eligibility Diabetes Mellitus NCT00355537

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male patients greater than 18 years of age
Descripción

Gender | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
type 2 diabetes mellitus
Descripción

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
serum testosterone less than 11 nmol/l on two consecutive samples taken on different days
Descripción

Serum testosterone measurement CONSECUTIVE SAMPLE Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0428413
UMLS CUI [1,2]
C0150094
UMLS CUI [1,3]
C1265611
peripheral vascular disease as defined by abpi less than 0.92 and ischaemic leg pain (claudication or rest pain) or distal complications (non-healing arterial foot ulcer or gangrene
Descripción

Peripheral Vascular Disease Ankle brachial pressure index | Pain in lower limb Ischemic | Claudication | Rest pain | Complication Distal | FOOT ULCER UNHEALED Arterial | Gangrene Non-healed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0085096
UMLS CUI [1,2]
C1276055
UMLS CUI [2,1]
C0023222
UMLS CUI [2,2]
C0475224
UMLS CUI [3]
C1456822
UMLS CUI [4]
C0234253
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0205108
UMLS CUI [6,1]
C0744185
UMLS CUI [6,2]
C0221464
UMLS CUI [7,1]
C0017086
UMLS CUI [7,2]
C0205301
agreement to maintain antihypertensive and anti-lipid treatments at prior doses during 3 months of study
Descripción

Antihypertensive therapy Dosage Maintenance | Antilipidemic Agent Dosage Maintenance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0585941
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0024501
UMLS CUI [2,1]
C1516000
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0024501
ability to give written informed consent after verbal and written explanation in the english language
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
ability to comply with all study requirements
Descripción

Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
current or previous breast cancer
Descripción

Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
current or previous prostate cancer
Descripción

Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
raised prostate specific antigen or abnormal per rectal examination unless prostate cancer excluded after specialist urology opinion
Descripción

Raised prostate specific antigen | Prostate specific antigen abnormal Rectal examination | Prostate carcinoma Exclusion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0178415
UMLS CUI [2,1]
C0580555
UMLS CUI [2,2]
C0199900
UMLS CUI [3,1]
C0600139
UMLS CUI [3,2]
C2828389
severe symptoms of benign prostatic hypertrophy ('prostatism')
Descripción

Benign prostatic hypertrophy Symptom severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1704272
UMLS CUI [1,2]
C0436345
treatment with testosterone in the 3 months prior to the trial
Descripción

Testosterone

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0039601
investigational drug treatment in the 3 months prior to the trial
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus NCT00355537

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
male patients greater than 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Serum testosterone measurement CONSECUTIVE SAMPLE Quantity
Item
serum testosterone less than 11 nmol/l on two consecutive samples taken on different days
boolean
C0428413 (UMLS CUI [1,1])
C0150094 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Peripheral Vascular Disease Ankle brachial pressure index | Pain in lower limb Ischemic | Claudication | Rest pain | Complication Distal | FOOT ULCER UNHEALED Arterial | Gangrene Non-healed
Item
peripheral vascular disease as defined by abpi less than 0.92 and ischaemic leg pain (claudication or rest pain) or distal complications (non-healing arterial foot ulcer or gangrene
boolean
C0085096 (UMLS CUI [1,1])
C1276055 (UMLS CUI [1,2])
C0023222 (UMLS CUI [2,1])
C0475224 (UMLS CUI [2,2])
C1456822 (UMLS CUI [3])
C0234253 (UMLS CUI [4])
C0009566 (UMLS CUI [5,1])
C0205108 (UMLS CUI [5,2])
C0744185 (UMLS CUI [6,1])
C0221464 (UMLS CUI [6,2])
C0017086 (UMLS CUI [7,1])
C0205301 (UMLS CUI [7,2])
Antihypertensive therapy Dosage Maintenance | Antilipidemic Agent Dosage Maintenance
Item
agreement to maintain antihypertensive and anti-lipid treatments at prior doses during 3 months of study
boolean
C0585941 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0024501 (UMLS CUI [1,3])
C1516000 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0024501 (UMLS CUI [2,3])
Informed Consent
Item
ability to give written informed consent after verbal and written explanation in the english language
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
ability to comply with all study requirements
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Breast Carcinoma
Item
current or previous breast cancer
boolean
C0678222 (UMLS CUI [1])
Prostate carcinoma
Item
current or previous prostate cancer
boolean
C0600139 (UMLS CUI [1])
Raised prostate specific antigen | Prostate specific antigen abnormal Rectal examination | Prostate carcinoma Exclusion
Item
raised prostate specific antigen or abnormal per rectal examination unless prostate cancer excluded after specialist urology opinion
boolean
C0178415 (UMLS CUI [1])
C0580555 (UMLS CUI [2,1])
C0199900 (UMLS CUI [2,2])
C0600139 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
Benign prostatic hypertrophy Symptom severe
Item
severe symptoms of benign prostatic hypertrophy ('prostatism')
boolean
C1704272 (UMLS CUI [1,1])
C0436345 (UMLS CUI [1,2])
Testosterone
Item
treatment with testosterone in the 3 months prior to the trial
boolean
C0039601 (UMLS CUI [1])
Investigational New Drugs
Item
investigational drug treatment in the 3 months prior to the trial
boolean
C0013230 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial